Filing Details
- Accession Number:
- 0001127602-12-003435
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-01 18:41:03
- Reporting Period:
- 2012-01-30
- Filing Date:
- 2012-02-01
- Accepted Time:
- 2012-02-01 18:41:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491654 | J.w. Thomas Dittrich | One Amgen Center Drive Thousand Oaks CA 91320 | Vp, Finance & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-30 | 11,000 | $62.55 | 22,952 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-01-30 | 9,000 | $42.13 | 31,952 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-01-30 | 4,000 | $50.44 | 35,952 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-01-30 | 2,150 | $58.43 | 38,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-30 | 26,150 | $68.26 | 11,952 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-01-30 | 11,000 | $0.00 | 11,000 | $62.55 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-01-30 | 9,000 | $0.00 | 9,000 | $42.13 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-01-30 | 4,000 | $0.00 | 4,000 | $50.44 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2012-01-30 | 2,150 | $0.00 | 2,150 | $58.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-04-26 | 2014-04-26 | No | 4 | M | Direct |
| 3,000 | 2009-04-29 | 2015-04-29 | No | 4 | M | Direct |
| 4,000 | 2010-04-28 | 2016-04-28 | No | 4 | M | Direct |
| 6,450 | 2011-04-26 | 2020-04-26 | No | 4 | M | Direct |
Footnotes
- The price reported is an average price. The prices ranged from $68.21 to $68.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
Billionaire Hedge Funds
